Compare Marvell Technology Inc (MRVL) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Oscar Health Inc — how do they compare? Marvell Technology Inc trades at $231.08 (market cap $211.20B), while Oscar Health Inc trades at $31.75 (market cap $9.80B). The key difference: Marvell Technology Inc is far larger — about 21.6× Oscar Health Inc's market cap, and Marvell Technology Inc pays a 0.1% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| MRVL | OSCR | |
|---|---|---|
Market Cap | $211.20B | $9.80B |
Sector | Technology | Health |
52-Week High | $316.43 | $33.01 |
52-Week Low | $66.59 | $10.85 |
Enterprise Value | $212.56B | $6.16B |
Dividend Yield | 0.1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marvell Technology (MRVL) trades at $225.41, up 0.83% with strong technical momentum and bullish moving average signals. The company demonstrates robust revenue growth with Q2 2026 EPS beating expectations at $0.94 versus $0.934, while management projects revenue reaching $12 billion this fiscal year and $18 billion next year. Analyst consensus remains overwhelmingly positive with 82% buy ratings and a $303.11 price target, representing 35% upside potential from current levels.
Marvell's AI-driven growth trajectory presents significant opportunity, though investors face risks from high valuation multiples (P/E 74.02) and competitive pressures in the semiconductor space. The stock's recent 31% pullback from yearly highs offers potential entry point for growth-oriented investors, supported by strong institutional accumulation and positive earnings momentum heading into October's Investor Day event.
OSCR trades at $33.01, up 2.36% today and near its 52-week high of $33.10, with a bullish technical trend supported by moving averages. The stock shows strong momentum, with Q1 and Q2 2026 earnings beating estimates, and revenue growth from $11.70B in 2025 to $15.30B in 2026. Analyst sentiment is mixed, with a consensus price target of $30.67 below the current price, but recent news highlights membership growth and cost control improvements.
The outlook for OSCR is cautiously optimistic, driven by robust revenue expansion and profitability improvements, though risks include high valuation multiples and reliance on sustained membership growth. Investors may find opportunity in the company's operational turnaround, but should monitor medical cost trends and competitive pressures in the health insurance sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
